These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21079553)

  • 1. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
    Kosmoliaptsis V; Sharples LD; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
    Transplantation; 2011 Jan; 91(2):183-90. PubMed ID: 21079553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
    Kosmoliaptsis V; Chaudhry AN; Sharples LD; Halsall DJ; Dafforn TR; Bradley JA; Taylor CJ
    Transplantation; 2009 Sep; 88(6):791-8. PubMed ID: 19920778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation.
    Kosmoliaptsis V; Sharples LD; Chaudhry A; Johnson RJ; Fuggle SV; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2010 Sep; 71(9):851-6. PubMed ID: 20538027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.
    Kosmoliaptsis V; Bradley JA; Sharples LD; Chaudhry A; Key T; Goodman RS; Taylor CJ
    Transplantation; 2008 Jun; 85(12):1817-25. PubMed ID: 18580476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.
    Mallon DH; Kling C; Robb M; Ellinghaus E; Bradley JA; Taylor CJ; Kabelitz D; Kosmoliaptsis V
    J Immunol; 2018 Dec; 201(12):3780-3792. PubMed ID: 30429288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
    Jucaud V
    J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HLA class II antibodies in kidney retransplant patients.
    Arnold ML; Pei R; Spriewald B; Wassmuth R
    Tissue Antigens; 2005 Apr; 65(4):370-8. PubMed ID: 15787721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and electrostatic analysis of HLA B-cell epitopes: inference on immunogenicity and prediction of humoral alloresponses.
    Mallon DH; Bradley JA; Taylor CJ; Kosmoliaptsis V
    Curr Opin Organ Transplant; 2014 Aug; 19(4):420-7. PubMed ID: 24977436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
    Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
    Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes.
    Kosmoliaptsis V; Dafforn TR; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2011 Nov; 72(11):1049-59. PubMed ID: 21840357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.